Multiparameter analysis of IL-4 and IL-13 participation in mycobacterial (type-1) and schistosomal (type-2)antigen-elicited granuloma formation

被引：0
|
作者：
Chensue, SW
Warmington, KS
Lincoln, P
Evanoff, H
Kunkel, SL
Ruth, JH
机构：
[1] Univ Michigan, Sch Med, Ann Arbor, MI 48105 USA
[2] Vet Affairs Med Ctr, Ann Arbor, MI 48105 USA
来源：
FASEB JOURNAL | 1999年 / 13卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A318 / A318
页数：1
相关论文
共 50 条
  • [31] Dual blockade of IL-4 and IL-13 with dupilumab, an IL-4Rα antibody, is required to broadly inhibit type 2 inflammation
    Le Floch-ramondou, Audrey
    Nagashima, Kirsten
    Scott, George
    Birchard, Dylan
    Asrat, Seblewongel
    Bai, Yu
    Lim, Wei Keat
    Murphy, Andrew
    Sleeman, Matthew
    Orengo, Jamie
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (02) : AB158 - AB158
  • [32] Differential Regulation of the Type 2 Cytokines, IL-4 and IL-13, and the Alarmins, IL-33 and TSLPA, in Airway Inflammation and Remodeling
    Asrat, S.
    Srivatsan, S.
    Buonagurio, B.
    Nagashima, K.
    Scott, G.
    Gayvert, K.
    Lim, W.
    Ben, L.
    Le Floc'h, A.
    Murphy, A. J.
    Sleeman, M.
    Orengo, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [33] IL-4/IL-13 antagonist DNA vaccination successfully suppresses Th2 type chronic dermatitis
    Morioka, T.
    Yamanaka, K.
    Mori, H.
    Omoto, Y.
    Tokime, K.
    Kakeda, M.
    Kurokawa, I.
    Gabazza, E. C.
    Tsubura, A.
    Yasutomi, Y.
    Mizutani, H.
    BRITISH JOURNAL OF DERMATOLOGY, 2009, 160 (06) : 1172 - 1179
  • [34] IFN-γ and IL-10 inhibit induction of IL-1 receptor type I and type II gene expression by IL-4 and IL-13 in human monocytes
    Dickensheets, HL
    Donnelly, RP
    JOURNAL OF IMMUNOLOGY, 1997, 159 (12): : 6226 - 6233
  • [35] IL-13 modulates phenotypic profile of type 1 and type 2 fibroblasts
    Jakubzick, CV
    Campbell, E
    Westwick, J
    Evanoff, H
    Hogaboam, C
    Kunkel, S
    FASEB JOURNAL, 2002, 16 (04): : A595 - A595
  • [36] Chemokinome characterization in human lung macrophages following stimulation with Th2-type cytokines IL-4 or IL-13
    Delyle, Stanislas Grassin
    Buenestado, Amparo
    Abrial, Charlotte
    Brollo, Marion
    Naline, Emmanuel
    Devillier, Philippe
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [37] IN-VIVO REGULATION OF MACROPHAGE IL-12 PRODUCTION DURING TYPE-1 AND TYPE-2 CYTOKINE-MEDIATED GRANULOMA-FORMATION
    CHENSUE, SW
    RUTH, JH
    WARMINGTON, K
    LINCOLN, P
    KUNKEL, SL
    JOURNAL OF IMMUNOLOGY, 1995, 155 (07): : 3546 - 3551
  • [38] Dual blockade of IL-4 and IL-13 with dupilumab reduces severity of type 2 inflammatory immune-related adverse events
    Lee, C.
    Chung, W.
    Chen, C.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S84 - S84
  • [39] Type 2 immunity is controlled by IL-4/IL-13 expression in hematopoietic non-eosinophil cells of the innate immune system
    Voehringer, David
    Reese, Tiffany A.
    Huang, Xiaozhu
    Shinkai, Kanade
    Locksley, Richard M.
    JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203 (06): : 1435 - 1446
  • [40] Type-I and type-II interferons inhibit activation of STAT6 by IL-4 and IL-13 in human monocytes
    Dickensheets, HL
    Donnelly, RP
    JOURNAL OF LEUKOCYTE BIOLOGY, 1998, : 32 - 32
12345